Reshma Kewalramani - Sep 16, 2021 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Role
Director
Signature
/s/ Karen Tepichin, Attorney-in-fact
Stock symbol
DNA
Transactions as of
Sep 16, 2021
Transactions value $
$0
Form type
4
Date filed
9/20/2021, 09:51 PM
Previous filing
Aug 23, 2021
Next filing
Nov 23, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Stock Option Award $0 +51.8K $0.00 51.8K Sep 16, 2021 Class A Common Stock 51.8K $11.42 Direct F1
transaction DNA Stock Option Award $0 +17.6K $0.00 17.6K Sep 16, 2021 Class A Common Stock 17.6K $11.42 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in three substantially equal annual installments beginning on September 16, 2022.
F2 The stock option vests on the earlier of either September 16, 2022 or the day before the Issuer's next annual meeting of stockholders.